Standalone figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | 29.5% | 31.9% | 33.9% |
| EBITDA margin % | 10.5% | 11.7% | 10.5% |
Standalone figures
| Ratio | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Margins | |||
| Gross margin % | 29.5% | 31.9% | 33.9% |
| EBITDA margin % | 10.5% | 11.7% | 10.5% |
| EBIT margin % |
| 6.7% |
| 7.8% |
| 6.7% |
| PAT margin % | 3.4% | 4.7% | 2.4% |
| Working capital | |||
| Receivable days | 84 | 79 | 101 |
| Inventory days | 64 | 42 | 46 |
| Payable days | 170 | 153 | 188 |
| NWC days | -23 | -32 | -41 |
| Leverage | |||
| Current ratio | 1.06 | 1.32 | 1.26 |
| Debt to EBITDA | 1.82 | 1.54 | 2.83 |
| Debt to equity | 0.8 | 0.47 | 0.71 |
| Interest coverage | 2.2 | 2.3 | 1.7 |
| Asset turnover | 0.83 | 0.75 | 0.64 |
| Return ratios | |||
| Return on assets % | 2.8% | 3.5% | 1.6% |
| Return on capital employed % | 21.3% | 20.3% | 13.8% |
| Return on equity % | 14.4% | 12.1% | 5.8% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.